Early today we reported on the Times profiling GW Pharma.
The Guardian have published, as far as we are aware, their most detailed profile on the subject yet.
Here’s what they are saying via their well informed LA correspondent, Alex Halperin.
What is CBD? The ‘miracle’ cannabis compound that doesn’t get you high
The cannabis-derived chemical is non-psychoactive, and – while federally illegal – has been hailed as a cure for disease
In early May, a federal court declined to protect cannabidiol (CBD), a chemical produced by the cannabis plant, from federal law enforcement, despite widespread belief in its medical value.
The ruling was contrary to existing evidence, which suggests the chemical is safe and could have multiple important uses as medicine. Many cannabis advocates consider it a miracle medicine, capable of relieving conditions as disparate as depression, arthritis and diabetes.
The perception of its widespread medical benefits have made the chemical a rallying cry for legalization advocates.
The first thing to know about CBD is that it is not psychoactive; it doesn’t get people high. The primary psychoactive ingredient in marijuana is tetrahydrocannabinol (THC). But THC is only one of the scores of chemicals – known as cannabinoids – produced by the cannabis plant.
So far, CBD is the most promising compound from both a marketing and a medical perspective. Many users believe it helps them relax, despite it not being psychoactive, and some believe regular doses help stave off Alzheimer’s and heart disease.
More at the link
https://www.theguardian.com/society/2018/may/28/what-is-cbd-cannabidiol-cannabis-medical-uses
